Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
AIDS 2014: Financing the new global HIV treatment vision – advocacy and economics

The USAID- and PEPFAR-funded Health Policy Project’s own estimates of the global costs of reaching extremely high levels of ART coverage in low and middle-income countries suggest that between U.S.$5.5 to $9 billion might be required annually to meet this goal by 2020.

Published
8 hours ago
From
Science Speaks
Funding for HIV prevention for people who inject drugs is in crisis, experts warn

Harm Reduction International, the International Drug Policy Consortium and the International HIV/Aids Alliance will publish a report that confirms HIV prevention services for drug injectors are losing out due to "changing donor policies and national government neglect".

Published
20 July 2014
From
The Observer
Declining investment could slow research and rollout of new HIV prevention options

Investment in HIV prevention research fell US$50 million, or 4 percent, to US$1.26 billion in 2013, due to declining investments by the United States and European government donors, changes in the international development landscape and changes in the pipeline of HIV prevention products in various stages of development and implementation, according to a new report from the HIV Vaccines and Microbicides Resource Tracking Working Group.

Published
20 July 2014
From
HIV Vaccines and Microbicides Resource Tracking Working Group press release
Kaiser/UNAIDS Study Finds Dip in Donor Government Commitments for AIDS In 2013

Donor governments in 2013 committed US$8.1 billion in new funding to support the AIDS response in low- and middle-income countries, down 3 percent from 2012, finds a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) released in advance of the 2014 International AIDS Conference.

Published
19 July 2014
From
Kaiser Family Foundation
Why HIV Drug Costs Are Spiking Under Obamacare

Since the start of this year, many people with HIV have seen the out-of-pocket costs of their medications skyrocket. And advocates argue it’s not just price-gouging, but a blatant attempt by insurance companies to discriminate against patients who need expensive treatments.

Published
17 July 2014
From
Buzzfeed
Complaint Says Insurance Plans Discriminate Against HIV Patients

Four Florida insurers allegedly discriminate against people with HIV/AIDS by structuring their prescription drug benefits so that patients are discouraged from enrolling, according to a complaint filed by health advocacy groups.

Published
09 July 2014
From
NPR
HIV interventions will not reach those who need them without increased efficiencies, review says

While noting that HIV service delivery can’t be increased to needed levels with reduced resources, authors of a systematic review published in the July World Health Organization Bulletin say more efficient use of existing resources will be critical to making meaningful reductions in prevalence and infection rates.

Published
04 July 2014
From
Science Speaks
Too soon for rich countries to stop HIV funding in poor ones

The international community expects governments of low- and middle-income countries to invest more funds in their HIV responses, and to move towards fully domestically financed responses. But the political, social, economic and infrastructural factors in many low- and middle-income countries preclude domestic leadership for comprehensive HIV responses.

Published
04 July 2014
From
The Conversation
New ARV prescribing guidelines for London (2014)

The guidelines are the result of a therapeutic tender, which encourages drug manufacturers to offer volume discounts for different stages of the treatment pathway, for example, for preferred use in first-line, second-line and multiple resistant treatment.

Published
01 July 2014
From
HIV i-Base
Why HIV Drug Costs Are Spiking Under Obamacare

Since the start of this year, many people with HIV have seen the out-of-pocket costs of their medications skyrocket. And advocates argue it's not just price-gouging, but a blatant attempt to discriminate against patients who need expensive treatments.

Published
01 July 2014
From
BuzzFeed
← First12345...67Next →

Filter by country